Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Severe loss of circulating dendritic cell subsets in splenectomised children with sickle cell disease
source: American Society of Pediatric Hematology/Oncology
year: 2017
authors: Mohamed-Rachid Boulassel, Amal Al-Naamani, Zahra Al-Qarni, Hanan Nazir, Ahmed Al-Yarabi, Mohammad Hunieni, Abdulhakim Al-Rawas, Yasser Wali
summary/abstract:Splenectomy is the mainstay of long-term management of sickle cell disease (SCD) patients with frequent splenic sequestration crisis. However, it exposes patients to increased risk of infections, which remain major concern for both patients and clinicians. Dendritic cells (DC) play a key role in priming immune responses against infections. To date, limited information is available about DC subsets and their clinical relevance in splenectomised children with SCD.
A total of 57 SCD children who underwent open splenectomy were prospectively enrolled. Twenty eight age- and sex-matched healthy children were recruited as controls. The indication of splenectomy was based on the history of patients, clinical examination, hematological and radiological findings. The circulating DC subsets including plasmacytoid DC (pDC) and myeloid DC (mDC) were phenotypically identified by the expression of HLA-DR, CD123, CD11c, Lin and CD1d surface markers using 8-color flow cytometry. The B cell subsets were characterized by the positive staining with CD19, CD24 and CD38 surface markers. Comparisons among study groups were performed using unpaired t test, while the Spearman’s correlation was used to assess associations.
Compared to healthy controls, splenectomised children exhibited significantly lower levels of pDC (P=0.02). Similarly, levels of mDC were significantly reduced in splenectomised children compared to healthy controls (0.009). Interestingly, levels of pDC expressing CD1d, a non-classical molecule that is critical for generating cytokines from innate cells, were significantly reduced in splenectomised children compared to healthy controls (P<0.001).
Levels of memory B cells, but not total and naïve B cells, were also significantly lower in splenectomised children compared to healthy controls (P=0.02). The levels of pDC and mDC were weakly associated with memory B cells (r=0.41, P=0.04), but not with age, total hemoglobin levels at phlebotomy, baseline haemoglobin F, time since splenectomy, hydroxyurea therapy and clinical severity.
read moreRelated Content
-
At 16, She’s a Pioneer in the Fight to Cure Sickle Cell DiseaseHelen Obando, a shy slip of a girl, lay ...
-
Discovery could help treatments for sickle cell diseaseResearch team establishes biomarkers for...
-
Practice variation in emergency department management of children with sickle cell disease who present with feverOBJECTIVES:Urgent medical evaluation is ...
-
Imara’s IMR-687 for SCD Receives FDA Rare Pediatric Disease DesignationThe U.S. Food and Drug Administration (F...
-
Methadone provides pain relief for kids with sickle cellMany children with sickle cell disease e...
-
Preoperative blood transfusions for sickle cell diseaseBackground: Sickle cell disease is one ...
-
Family Celebrates 7-Year-Old’s Sickle Cell Cure Thanks to Sister’s Life-Saving GiftOne 7-year-old who suffered his whole li...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
+myBinder